Americans hungry for weight-loss drugs grapple with supply and insurance hurdles

Despite supply chain issues easing, patients seeking weight-loss drugs like Wegovy and Zepbound are turning to cheaper compounded versions sold online. High costs and insurance hurdles are driving this trend, even as manufacturers work to increase availability and curb the use of less-regulated alternatives. Despite supply chain issues easing, patients seeking weight-loss drugs like Wegovy and Zepbound are turning to cheaper compounded versions sold online. High costs and insurance hurdles are driving this trend, even as manufacturers work to increase availability and curb the use of less-regulated alternatives.  Economic Times